phenyl acetate has been researched along with Dementia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Götz, J; Ittner, LM; Nilsen, LH; Rae, C; Sonnewald, U | 1 |
| CHESROW, EJ; KAPLITZ, SE; LEVINE, JM; MUSCI, JP; SABATINI, R | 1 |
| JACQUEL, G; MOREL, J; ROBERT, G | 1 |
| Antonello, RM; Bava, A; Cazzato, G; Moretti, R; Torre, P | 1 |
| Ancill, RJ; Holliday, SG; Sheldon, LJ | 1 |
| Basavaraju, N; Goldenberg, G; Kahaner, K; Rangu, S | 1 |
| Herrmann, N; Lanctôt, K; Myszak, M | 1 |
| Hawkins, JW; Peyser, CE; Sheikh, JI; Tinklenberg, JR; Yesavage, JA | 1 |
| Pozzessere, G; Rossi, P; Serrao, M | 1 |
| Bowers, MB; Reynolds, EH | 1 |
| Exton-Smith, AN; Gedye, JL; Wedgwood, J | 1 |
| Stegink, AJ | 1 |
| Szilágyi, KA | 1 |
4 trial(s) available for phenyl acetate and Dementia
| Article | Year |
|---|---|
Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation.
Topics: Acetates; Aged; Amines; Anti-Anxiety Agents; Comorbidity; Cyclohexanecarboxylic Acids; Dementia; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Mental Disorders; Treatment Outcome | 2003 |
Effectiveness of gabapentin for the treatment of behavioral disorders in dementia.
Topics: Acetates; Aged; Aged, 80 and over; Amines; Anti-Anxiety Agents; Behavioral Symptoms; Cyclohexanecarboxylic Acids; Dementia; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Prospective Studies; Psychomotor Agitation | 2000 |
A method for measuring mental performance in the elderly and its use in a pilot clinical trial of meclofenoxate in organic dementia (preliminary communication).
Topics: Acetates; Administration, Oral; Aged; Central Nervous System Stimulants; Clinical Trials as Topic; Dementia; Female; Humans; Learning; Male; Meclofenoxate; Mental Processes; Neurocognitive Disorders; Paired-Associate Learning; Placebos; Programmed Instructions as Topic; Task Performance and Analysis | 1972 |
The clinical use of piracetam, a new nootropic drug. The treatment of symptoms of senile involution.
Topics: Acetamides; Acetates; Adult; Aged; Amides; Asthenia; Clinical Trials as Topic; Dementia; Depression; Headache; Humans; Hypochondriasis; Memory Disorders; Middle Aged; Perceptual Disorders; Placebos; Psychomotor Disorders; Pyrrolidinones; Sleep Wake Disorders; Vertigo | 1972 |
9 other study(ies) available for phenyl acetate and Dementia
| Article | Year |
|---|---|
Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation.
Topics: Acetates; Animals; Astrocytes; Cerebellar Cortex; Dementia; Female; gamma-Aminobutyric Acid; Glucose; Glutamic Acid; Hippocampus; Humans; Male; Mice; Mice, Transgenic; Mutation; Neurons; Neurotransmitter Agents; Phosphorylation; tau Proteins; Transgenes | 2013 |
Use of ethyltryptamine acetate in parkinsonism and senility with depressive states. Study of 65 cases.
Topics: Acetates; Antidepressive Agents; Dementia; Depression; Humans; Indoles; Parkinson Disease; Parkinsonian Disorders; Psychotic Disorders | 1962 |
[Centrophenoxine in the treatment of confusional syndromes and intellectual deficiency].
Topics: Acetates; Brain Diseases; Central Nervous System Stimulants; Coma; Dementia; Humans; Intellectual Disability; Korsakoff Syndrome; Meclofenoxate; Mental Disorders; Paresis; Psychotic Disorders | 1963 |
Gabapentin in geriatric psychiatry patients.
Topics: Acetates; Aged; Aged, 80 and over; Alzheimer Disease; Amines; Anticonvulsants; Bipolar Disorder; Cyclohexanecarboxylic Acids; Dementia; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male | 1998 |
Gabapentin for disruptive behaviour in an elderly demented patient.
Topics: Acetates; Aged; Aged, 80 and over; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Dementia; Dose-Response Relationship, Drug; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; New York; Nursing Homes; Psychomotor Agitation | 1998 |
A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias.
Topics: Acetates; Aged; Aged, 80 and over; Aggression; Amines; Antimanic Agents; California; Cyclohexanecarboxylic Acids; Dementia; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Humans; Inpatients; Male; Medical Records; Middle Aged; Nursing Homes; Retrospective Studies; Social Behavior Disorders; Treatment Outcome | 2000 |
Gabapentin-induced worsening of neuropsychiatric symptoms in dementia with lewy bodies: case reports.
Topics: Acetates; Aged; Amines; Cyclohexanecarboxylic Acids; Dementia; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lewy Bodies; Male; Mental Health; Nervous System | 2002 |
Cerebrospinal-fluid folate and acid monoamine metabolites.
Topics: Acetates; Biogenic Amines; Dementia; Folic Acid; Humans; Hydroxyindoleacetic Acid; Phenols | 1972 |
[Determination of guanidinoacetic acid concentration in serum and cerebrospinal fluid].
Topics: Acetates; Adult; Age Factors; Aged; Alcoholism; Arginine; Chromatography, Gel; Dementia; Depression; Epilepsy; Guanidines; Humans; Intracranial Arteriosclerosis; Mental Disorders; Methods; Middle Aged; Neurotic Disorders; Schizophrenia | 1970 |